Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Renalys Pharma Inc announced today that the first person was dosed in its registrational Phase III clinical trial of sparsentan for the treatment of IgA nephropathy in Japan In April this year Renalys submitted
Immutep Limited a clinicalstage biotechnology company developing novel LAG immunotherapies for cancer and autoimmune disease today announces it has received regulatory clearance
Anixa Biosciences Inc a biotechnology company focused on the treatment and prevention of cancer today announced that its collaborator Cleveland Clinic has received a Decision to Grant notice from the Japan Patent Office
Renalys Pharma Inc a latestage clinical biopharmaceutical company has completed a Bn Series A financing The financing was led by Catalys Pacific and SR One along with additional investors
Sanyou Biopharmaceuticals Co Ltd has recently announced a significant milestone in collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Biosyngen a leading biotechnology company focused on the development of innovative cell therapies recently announced that the Center for Drug Evaluation
AstraZeneca today announced the successful completion of the acquisition of Amolyt Pharma a clinicalstage biotechnology company focused on developing novel treatments for rare endocrine diseases The acquisition bolsters the Alexion AstraZeneca Rare D...
Diakonos Oncology Corporation a clinical stage immunooncology company announced today that the US Food and Drug Administration has granted Fast Track designation
Rise Therapeutics a clinicalstage biotechnology company developing novel oral immunotherapeutic medicines today announced that it has enrolled its first patient in its R placebo controlled blinded Phase b type diabetes clinical trial Gary Fanger Pre...
Mabwell an innovative biopharmaceutical company with entire industry chain announces that its selfdeveloped novel Nectintargeting ADC has been granted Fast Track Designation
